355 related articles for article (PubMed ID: 23689532)
21. Sustained response to low-dose rituximab in idiopathic autoimmune hemolytic anemia.
Barcellini W; Zaja F; Zaninoni A; Imperiali FG; Di Bona E; Fattizzo B; Consonni D; Cortelezzi A; Zanella A
Eur J Haematol; 2013 Dec; 91(6):546-51. PubMed ID: 24033754
[TBL] [Abstract][Full Text] [Related]
22. Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia.
Gupta N; Kavuru S; Patel D; Janson D; Driscoll N; Ahmed S; Rai KR
Leukemia; 2002 Oct; 16(10):2092-5. PubMed ID: 12357362
[TBL] [Abstract][Full Text] [Related]
23. Warm autoimmune hemolytic anemia.
Naik R
Hematol Oncol Clin North Am; 2015 Jun; 29(3):445-53. PubMed ID: 26043384
[TBL] [Abstract][Full Text] [Related]
24. Treatment of autoimmune hemolytic anemia.
King KE; Ness PM
Semin Hematol; 2005 Jul; 42(3):131-6. PubMed ID: 16041662
[TBL] [Abstract][Full Text] [Related]
25. [Autoimmune hemolytic anemia].
Gerber B; Schanz U; Stüssi G
Ther Umsch; 2010 May; 67(5):229-36. PubMed ID: 20509119
[TBL] [Abstract][Full Text] [Related]
26. Two cases of refractory warm autoimmune hemolytic anemia treated with rituximab.
Ramanathan S; Koutts J; Hertzberg MS
Am J Hematol; 2005 Feb; 78(2):123-6. PubMed ID: 15682420
[TBL] [Abstract][Full Text] [Related]
27. Rituximab for refractory childhood autoimmune hemolytic anemia.
Motto DG; Williams JA; Boxer LA
Isr Med Assoc J; 2002 Nov; 4(11):1006-8. PubMed ID: 12489491
[TBL] [Abstract][Full Text] [Related]
28. [Progress in diagnosis and treatment of autoimmune hemolytic disorders].
Kamesaki T
Rinsho Ketsueki; 2017; 58(4):329-335. PubMed ID: 28484163
[TBL] [Abstract][Full Text] [Related]
29. Autoimmune hemolytic anemia following T cell-depleted allogeneic bone marrow transplantation.
Drobyski WR; Potluri J; Sauer D; Gottschall JL
Bone Marrow Transplant; 1996 Jun; 17(6):1093-9. PubMed ID: 8807120
[TBL] [Abstract][Full Text] [Related]
30. How I treat autoimmune hemolytic anemias in adults.
Lechner K; Jäger U
Blood; 2010 Sep; 116(11):1831-8. PubMed ID: 20548093
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune hemolytic anemia in pediatric liver or combined liver and small bowel transplant patients: a case series and review of the literature.
Li M; Goldfinger D; Yuan S
Transfusion; 2012 Jan; 52(1):48-54. PubMed ID: 21790626
[TBL] [Abstract][Full Text] [Related]
32. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
D'Arena G; Laurenti L; Capalbo S; D'Arco AM; De Filippi R; Marcacci G; Di Renzo N; Storti S; Califano C; Vigliotti ML; Tarnani M; Ferrara F; Pinto A
Am J Hematol; 2006 Aug; 81(8):598-602. PubMed ID: 16823816
[TBL] [Abstract][Full Text] [Related]
33. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
Shanafelt TD; Madueme HL; Wolf RC; Tefferi A
Mayo Clin Proc; 2003 Nov; 78(11):1340-6. PubMed ID: 14601692
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting.
Jäger U; Barcellini W; Broome CM; Gertz MA; Hill A; Hill QA; Jilma B; Kuter DJ; Michel M; Montillo M; Röth A; Zeerleder SS; Berentsen S
Blood Rev; 2020 May; 41():100648. PubMed ID: 31839434
[TBL] [Abstract][Full Text] [Related]
35. Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients.
Barcellini W; Fattizzo B; Zaninoni A; Radice T; Nichele I; Di Bona E; Lunghi M; Tassinari C; Alfinito F; Ferrari A; Leporace AP; Niscola P; Carpenedo M; Boschetti C; Revelli N; Villa MA; Consonni D; Scaramucci L; De Fabritiis P; Tagariello G; Gaidano G; Rodeghiero F; Cortelezzi A; Zanella A
Blood; 2014 Nov; 124(19):2930-6. PubMed ID: 25232059
[TBL] [Abstract][Full Text] [Related]
36. [Autoimmune hemolytic anemias].
Subran B; Montagner C; Lidove O
Rev Prat; 2020 Jan; 70(1):79-87. PubMed ID: 32877037
[TBL] [Abstract][Full Text] [Related]
37. Orthotopic liver transplantation after successful treatment with anti-CD20 monoclonal antibody (rituximab) for severe steroid-resistant autoimmune hemolytic anemia: a case report.
Annicchiarico BE; Siciliano M; Avolio AW; Agnes S; Bombardieri G
Transplant Proc; 2009 May; 41(4):1380-2. PubMed ID: 19460565
[TBL] [Abstract][Full Text] [Related]
38. [Efficacity of rituximab in hemolytic anemia with cold autoantibodies case].
Sekkach Y; Hammi S; Elqatni M; Fatihi J; Elomri N; Mekouar F; Badaoui M; Jira M; Smaali J; El Khattabi A; Amezyane T; Abouzahir A; Ghafir D
Ann Pharm Fr; 2011 Jul; 69(4):205-8. PubMed ID: 21840439
[TBL] [Abstract][Full Text] [Related]
39. Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia.
Peñalver FJ; Alvarez-Larrán A; Díez-Martin JL; Gallur L; Jarque I; Caballero D; Díaz-Mediavilla J; Bustelos R; Fernández-Aceñero MJ; Cabrera JR;
Ann Hematol; 2010 Nov; 89(11):1073-80. PubMed ID: 20526716
[TBL] [Abstract][Full Text] [Related]
40. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia.
Diehl LF; Ketchum LH
Semin Oncol; 1998 Feb; 25(1):80-97. PubMed ID: 9482530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
